Global Generic Oncology Drugs Market Size, Status and Forecast 2020-2026

May 2020 | 93 pages | ID: G8A30FE92C47EN
QYResearch

Abstracts

This report focuses on the global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Generic Oncology Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Pfizer
• GlaxoSmithKline
• Novartis
• Merck
• Celgene
• Teva Pharmaceutical
• Mylan
• Aurobindo Pharma
• Hikma Pharmaceuticals
• Natco Pharma

Market segment by Type, the product can be split into

• Large Molecule Drugs
• Small Molecule Drugs

Market segment by Application, split into

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key players.
• To present the Generic Oncology Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Generic Oncology Drugs are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Generic Oncology Drugs Revenue
1.4 Market Analysis by Type
  1.4.1 Global Generic Oncology Drugs Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Large Molecule Drugs
  1.4.3 Small Molecule Drugs
1.5 Market by Application
  1.5.1 Global Generic Oncology Drugs Market Share by Application: 2020 VS 2026
  1.5.2 Hospital Pharmacies
  1.5.3 Retail Pharmacies
  1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Generic Oncology Drugs Market Perspective (2015-2026)
2.2 Generic Oncology Drugs Growth Trends by Regions
  2.2.1 Generic Oncology Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Generic Oncology Drugs Historic Market Share by Regions (2015-2020)
  2.2.3 Generic Oncology Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Generic Oncology Drugs Market Growth Strategy
  2.3.6 Primary Interviews with Key Generic Oncology Drugs Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Generic Oncology Drugs Players by Market Size
  3.1.1 Global Top Generic Oncology Drugs Players by Revenue (2015-2020)
  3.1.2 Global Generic Oncology Drugs Revenue Market Share by Players (2015-2020)
  3.1.3 Global Generic Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Generic Oncology Drugs Market Concentration Ratio
  3.2.1 Global Generic Oncology Drugs Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Generic Oncology Drugs Revenue in 2019
3.3 Generic Oncology Drugs Key Players Head office and Area Served
3.4 Key Players Generic Oncology Drugs Product Solution and Service
3.5 Date of Enter into Generic Oncology Drugs Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Generic Oncology Drugs Historic Market Size by Type (2015-2020)
4.2 Global Generic Oncology Drugs Forecasted Market Size by Type (2021-2026)

5 GENERIC ONCOLOGY DRUGS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Generic Oncology Drugs Market Size by Application (2015-2020)
5.2 Global Generic Oncology Drugs Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Generic Oncology Drugs Market Size (2015-2020)
6.2 Generic Oncology Drugs Key Players in North America (2019-2020)
6.3 North America Generic Oncology Drugs Market Size by Type (2015-2020)
6.4 North America Generic Oncology Drugs Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Generic Oncology Drugs Market Size (2015-2020)
7.2 Generic Oncology Drugs Key Players in Europe (2019-2020)
7.3 Europe Generic Oncology Drugs Market Size by Type (2015-2020)
7.4 Europe Generic Oncology Drugs Market Size by Application (2015-2020)

8 CHINA

8.1 China Generic Oncology Drugs Market Size (2015-2020)
8.2 Generic Oncology Drugs Key Players in China (2019-2020)
8.3 China Generic Oncology Drugs Market Size by Type (2015-2020)
8.4 China Generic Oncology Drugs Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Generic Oncology Drugs Market Size (2015-2020)
9.2 Generic Oncology Drugs Key Players in Japan (2019-2020)
9.3 Japan Generic Oncology Drugs Market Size by Type (2015-2020)
9.4 Japan Generic Oncology Drugs Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Generic Oncology Drugs Market Size (2015-2020)
10.2 Generic Oncology Drugs Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Generic Oncology Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Generic Oncology Drugs Market Size by Application (2015-2020)

11 INDIA

11.1 India Generic Oncology Drugs Market Size (2015-2020)
11.2 Generic Oncology Drugs Key Players in India (2019-2020)
11.3 India Generic Oncology Drugs Market Size by Type (2015-2020)
11.4 India Generic Oncology Drugs Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Generic Oncology Drugs Market Size (2015-2020)
12.2 Generic Oncology Drugs Key Players in Central & South America (2019-2020)
12.3 Central & South America Generic Oncology Drugs Market Size by Type (2015-2020)
12.4 Central & South America Generic Oncology Drugs Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Pfizer
  13.1.1 Pfizer Company Details
  13.1.2 Pfizer Business Overview and Its Total Revenue
  13.1.3 Pfizer Generic Oncology Drugs Introduction
  13.1.4 Pfizer Revenue in Generic Oncology Drugs Business (2015-2020))
  13.1.5 Pfizer Recent Development
13.2 GlaxoSmithKline
  13.2.1 GlaxoSmithKline Company Details
  13.2.2 GlaxoSmithKline Business Overview and Its Total Revenue
  13.2.3 GlaxoSmithKline Generic Oncology Drugs Introduction
  13.2.4 GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2015-2020)
  13.2.5 GlaxoSmithKline Recent Development
13.3 Novartis
  13.3.1 Novartis Company Details
  13.3.2 Novartis Business Overview and Its Total Revenue
  13.3.3 Novartis Generic Oncology Drugs Introduction
  13.3.4 Novartis Revenue in Generic Oncology Drugs Business (2015-2020)
  13.3.5 Novartis Recent Development
13.4 Merck
  13.4.1 Merck Company Details
  13.4.2 Merck Business Overview and Its Total Revenue
  13.4.3 Merck Generic Oncology Drugs Introduction
  13.4.4 Merck Revenue in Generic Oncology Drugs Business (2015-2020)
  13.4.5 Merck Recent Development
13.5 Celgene
  13.5.1 Celgene Company Details
  13.5.2 Celgene Business Overview and Its Total Revenue
  13.5.3 Celgene Generic Oncology Drugs Introduction
  13.5.4 Celgene Revenue in Generic Oncology Drugs Business (2015-2020)
  13.5.5 Celgene Recent Development
13.6 Teva Pharmaceutical
  13.6.1 Teva Pharmaceutical Company Details
  13.6.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  13.6.3 Teva Pharmaceutical Generic Oncology Drugs Introduction
  13.6.4 Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2015-2020)
  13.6.5 Teva Pharmaceutical Recent Development
13.7 Mylan
  13.7.1 Mylan Company Details
  13.7.2 Mylan Business Overview and Its Total Revenue
  13.7.3 Mylan Generic Oncology Drugs Introduction
  13.7.4 Mylan Revenue in Generic Oncology Drugs Business (2015-2020)
  13.7.5 Mylan Recent Development
13.8 Aurobindo Pharma
  13.8.1 Aurobindo Pharma Company Details
  13.8.2 Aurobindo Pharma Business Overview and Its Total Revenue
  13.8.3 Aurobindo Pharma Generic Oncology Drugs Introduction
  13.8.4 Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2015-2020)
  13.8.5 Aurobindo Pharma Recent Development
13.9 Hikma Pharmaceuticals
  13.9.1 Hikma Pharmaceuticals Company Details
  13.9.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
  13.9.3 Hikma Pharmaceuticals Generic Oncology Drugs Introduction
  13.9.4 Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2015-2020)
  13.9.5 Hikma Pharmaceuticals Recent Development
13.10 Natco Pharma
  13.10.1 Natco Pharma Company Details
  13.10.2 Natco Pharma Business Overview and Its Total Revenue
  13.10.3 Natco Pharma Generic Oncology Drugs Introduction
  13.10.4 Natco Pharma Revenue in Generic Oncology Drugs Business (2015-2020)
  13.10.5 Natco Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Generic Oncology Drugs Key Market Segments
Table 2. Key Players Covered: Ranking by Generic Oncology Drugs Revenue
Table 3. Ranking of Global Top Generic Oncology Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Generic Oncology Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Large Molecule Drugs
Table 6. Key Players of Small Molecule Drugs
Table 7. Global Generic Oncology Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Generic Oncology Drugs Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Generic Oncology Drugs Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Generic Oncology Drugs Market Share by Regions (2015-2020)
Table 11. Global Generic Oncology Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Generic Oncology Drugs Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Generic Oncology Drugs Market Growth Strategy
Table 17. Main Points Interviewed from Key Generic Oncology Drugs Players
Table 18. Global Generic Oncology Drugs Revenue by Players (2015-2020) (Million US$)
Table 19. Global Generic Oncology Drugs Market Share by Players (2015-2020)
Table 20. Global Top Generic Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Oncology Drugs as of 2019)
Table 21. Global Generic Oncology Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Generic Oncology Drugs Product Solution and Service
Table 24. Date of Enter into Generic Oncology Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Generic Oncology Drugs Market Size by Type (2015-2020) (Million US$)
Table 27. Global Generic Oncology Drugs Market Size Share by Type (2015-2020)
Table 28. Global Generic Oncology Drugs Revenue Market Share by Type (2021-2026)
Table 29. Global Generic Oncology Drugs Market Size Share by Application (2015-2020)
Table 30. Global Generic Oncology Drugs Market Size by Application (2015-2020) (Million US$)
Table 31. Global Generic Oncology Drugs Market Size Share by Application (2021-2026)
Table 32. North America Key Players Generic Oncology Drugs Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Generic Oncology Drugs Market Share (2019-2020)
Table 34. North America Generic Oncology Drugs Market Size by Type (2015-2020) (Million US$)
Table 35. North America Generic Oncology Drugs Market Share by Type (2015-2020)
Table 36. North America Generic Oncology Drugs Market Size by Application (2015-2020) (Million US$)
Table 37. North America Generic Oncology Drugs Market Share by Application (2015-2020)
Table 38. Europe Key Players Generic Oncology Drugs Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Generic Oncology Drugs Market Share (2019-2020)
Table 40. Europe Generic Oncology Drugs Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Generic Oncology Drugs Market Share by Type (2015-2020)
Table 42. Europe Generic Oncology Drugs Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Generic Oncology Drugs Market Share by Application (2015-2020)
Table 44. China Key Players Generic Oncology Drugs Revenue (2019-2020) (Million US$)
Table 45. China Key Players Generic Oncology Drugs Market Share (2019-2020)
Table 46. China Generic Oncology Drugs Market Size by Type (2015-2020) (Million US$)
Table 47. China Generic Oncology Drugs Market Share by Type (2015-2020)
Table 48. China Generic Oncology Drugs Market Size by Application (2015-2020) (Million US$)
Table 49. China Generic Oncology Drugs Market Share by Application (2015-2020)
Table 50. Japan Key Players Generic Oncology Drugs Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Generic Oncology Drugs Market Share (2019-2020)
Table 52. Japan Generic Oncology Drugs Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Generic Oncology Drugs Market Share by Type (2015-2020)
Table 54. Japan Generic Oncology Drugs Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Generic Oncology Drugs Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Generic Oncology Drugs Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Generic Oncology Drugs Market Share (2019-2020)
Table 58. Southeast Asia Generic Oncology Drugs Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Generic Oncology Drugs Market Share by Type (2015-2020)
Table 60. Southeast Asia Generic Oncology Drugs Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Generic Oncology Drugs Market Share by Application (2015-2020)
Table 62. India Key Players Generic Oncology Drugs Revenue (2019-2020) (Million US$)
Table 63. India Key Players Generic Oncology Drugs Market Share (2019-2020)
Table 64. India Generic Oncology Drugs Market Size by Type (2015-2020) (Million US$)
Table 65. India Generic Oncology Drugs Market Share by Type (2015-2020)
Table 66. India Generic Oncology Drugs Market Size by Application (2015-2020) (Million US$)
Table 67. India Generic Oncology Drugs Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Generic Oncology Drugs Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Generic Oncology Drugs Market Share (2019-2020)
Table 70. Central & South America Generic Oncology Drugs Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Generic Oncology Drugs Market Share by Type (2015-2020)
Table 72. Central & South America Generic Oncology Drugs Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Generic Oncology Drugs Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. GlaxoSmithKline Company Details
Table 80. GlaxoSmithKline Business Overview
Table 81. GlaxoSmithKline Product
Table 82. GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 83. GlaxoSmithKline Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Merck Company Details
Table 90. Merck Business Overview
Table 91. Merck Product
Table 92. Merck Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 93. Merck Recent Development
Table 94. Celgene Company Details
Table 95. Celgene Business Overview
Table 96. Celgene Product
Table 97. Celgene Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 98. Celgene Recent Development
Table 99. Teva Pharmaceutical Company Details
Table 100. Teva Pharmaceutical Business Overview
Table 101. Teva Pharmaceutical Product
Table 102. Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 103. Teva Pharmaceutical Recent Development
Table 104. Mylan Company Details
Table 105. Mylan Business Overview
Table 106. Mylan Product
Table 107. Mylan Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 108. Mylan Recent Development
Table 109. Aurobindo Pharma Business Overview
Table 110. Aurobindo Pharma Product
Table 111. Aurobindo Pharma Company Details
Table 112. Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 113. Aurobindo Pharma Recent Development
Table 114. Hikma Pharmaceuticals Company Details
Table 115. Hikma Pharmaceuticals Business Overview
Table 116. Hikma Pharmaceuticals Product
Table 117. Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 118. Hikma Pharmaceuticals Recent Development
Table 119. Natco Pharma Company Details
Table 120. Natco Pharma Business Overview
Table 121. Natco Pharma Product
Table 122. Natco Pharma Revenue in Generic Oncology Drugs Business (2015-2020) (Million US$)
Table 123. Natco Pharma Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Generic Oncology Drugs Market Share by Type: 2020 VS 2026
Figure 2. Large Molecule Drugs Features
Figure 3. Small Molecule Drugs Features
Figure 4. Global Generic Oncology Drugs Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Generic Oncology Drugs Report Years Considered
Figure 9. Global Generic Oncology Drugs Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Generic Oncology Drugs Market Share by Regions: 2020 VS 2026
Figure 11. Global Generic Oncology Drugs Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Generic Oncology Drugs Market Share by Players in 2019
Figure 14. Global Top Generic Oncology Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Generic Oncology Drugs as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Generic Oncology Drugs Revenue in 2019
Figure 16. North America Generic Oncology Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Generic Oncology Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Generic Oncology Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Generic Oncology Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Generic Oncology Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Generic Oncology Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Generic Oncology Drugs Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. Pfizer Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 25. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. GlaxoSmithKline Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 29. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Merck Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 31. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Celgene Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 33. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Teva Pharmaceutical Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 35. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Mylan Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 37. Aurobindo Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Aurobindo Pharma Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 39. Hikma Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Hikma Pharmaceuticals Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 41. Natco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Natco Pharma Revenue Growth Rate in Generic Oncology Drugs Business (2015-2020)
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed